Parkinson’s disease dementia: Diagnostic criteria and risk factor review

REFERENCES

• Benito-León, J., Bermejo-Pareja, F., Rodríguez, J., Molina, J. A., Gabriel R., & Morales, J. M. (2003). Prevalence of PD and other types of parkinsonism in three elderly populations of central Spain. Movement Disorders, 18, 267–274.
   PubMed Web of Science ®Google Scholar
• Brucki, S. M., Nitrini, R., Caramelli, P., Bertolucci, P. H., & Okamoto, I. H. (2003). Suggestions for utilization of the mini-mental state examination in Brazil. Arquivos de Neuropsiquiatra, 61, 777–781.
   PubMed Web of Science ®Google Scholar
• Di Biasio, F., Vanacore, N., Fasano, A., Modugno, N., Gandolfi, B., Lena, F., & Ruggieri, S. (2012). Neuropsychology, neuroimaging or motor phenotype in diagnosis of Parkinson’s disease-dementia: Which matters most? Journal of Neural Transmission, 119, 597–604. doi:10.1007/s00702-011-0733-3
   PubMed Web of Science ®Google Scholar
• Dorsey, E. R., Constantinescu, R., Thompson, J. P., Biglan, K. M., Holloway, R. G., Kieburtz, K, … Tanner, C. M. (2007). Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology, 68, 384–386. doi:10.1212/01.wnl.0000247740.47667.03
   PubMed Web of Science ®Google Scholar
• Dubois, B., Burn, D., Goetz, C., Aarsland, D., Brown, R. G., Broe, G. A., & Emre, M. (2007). Diagnostic procedures for Parkinson’s disease dementia: Recommendations from the movement disorder society task force. Movement Disorders, 22, 2314–2324. doi:10.1002/mds.21844
   PubMed Web of Science ®Google Scholar
• Gescheidt, T., Mareček, R., Mikl, M., Czekóová, K., Urbánek, T., Vaníček, J., & Bareš, M. (2013). Functional anatomy of outcome evaluation during Iowa Gambling Task performance in patients with Parkinson’s disease: An fMRI study. Neurological Sciences, 34, 2159–2166. doi:10.1007/s10072-013-1439-0
   PubMed Web of Science ®Google Scholar
• Hindle, J. V. (2010). Ageing, neurodegeneration and Parkinson’s disease. Age and Ageing, 39, 156–161.
   PubMed Web of Science ®Google Scholar
• Hoops, S., Nazem, S., Siderowf, A. D., Duda, J. E., Xie, S. X., Stern, M. B., & Weintraub, D. (2009). Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology, 73, 1738–1745. doi:10.1212/WNL.0b013e3181c34b47
   PubMed Web of Science ®Google Scholar
• Isella, V., Mapelli, C., Siri, C., De Gaspari, D., Pezzoli, G., Antonini, A., & Appollonio, I. M. (2014). Validation and attempts of revision of the MDS-recommended tests for the screening of Parkinson’s disease dementia. Parkinsonism & Related Disorders, 20, 32–36. doi:10.1016/j.parkreldis.2013.09.008
   PubMed Web of Science ®Google Scholar
• Kehagia, A. A., Barker, R. A., & Robbins, T. W. (2013). Cognitive impairment in Parkinson’s disease: The dual syndrome hypothesis. Neurodegenerative Diseases, 11, 79–92. doi:10.1159/000341998
   PubMed Web of Science ®Google Scholar
• Litvan, I., Goldman, J. G., Tröster, A. I., Schmand, B. A., Weintraub, D., Petersen, R. C., … Emre, M. (2012). Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society Task Force guidelines. Movement Disorders, 27, 349–356. doi:10.1002/mds.24893
   PubMed Web of Science ®Google Scholar
• Martinez-Martin, P. (2013). Dementia in Parkinson’s disease: Usefulness of the pill questionnaire. Movement Disorders, 28, 1832–1837. doi:10.1002/mds.25649
   PubMed Web of Science ®Google Scholar
• Martinez-Martin, P., Falup-Pecurariu, C., Rodriguez-Blazquez, C., Serrano-Dueñas, M., Carod Artal, F. J., Rojo Abuin, J. M., & Aarsland, D. (2011). Dementia associated with Parkinson’s disease: Applying the Movement Disorder Society Task Force criteria. Parkinsonism & Related Disorders, 17, 621–624. doi:10.1016/j.parkreldis.2011.05.017
   PubMed Web of Science ®Google Scholar
• Muslimovic, D., Post, B., Speelman, J. D., & Schmand, B. (2005). Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology, 65, 1239–1245. doi:10.1212/01.wnl.0000180516.69442.95
   PubMed Web of Science ®Google Scholar
• Nagano-Saito, A., Martinu, K., & Monchi, O. (2014). Function of basal ganglia in bridging cognitive and motor modules to perform an action. Frontiers in Neuroscience, 8, 187. doi:10.3389/fnins.2014.00187
   PubMedGoogle Scholar
• Noe, E., Marder, K., Bell, K. L., Jacobs, D. M., Manly, J. J., & Stern, Y. (2004). Comparison of dementia with Lewy bodies to Alzheimer’s disease and Parkinson’s disease with dementia. Movement Disorders, 19, 60–67. doi:10.1002/mds.10633
   PubMed Web of Science ®Google Scholar
• Nombela, C., Rowe, J. B., Winder-Rhodes, S. E., Hampshire, A., Owen, A. M., Breen, D. P., & Barker, R. A. (2014). Genetic impact on cognition and brain function in newly diagnosed Parkinson’s disease: ICICLE-PD study. Brain, 137, 2743–2758. doi:10.1093/brain/awu201
   PubMed Web of Science ®Google Scholar
• Poletti, M., Emre, M., & Bonuccelli, U. (2011). Mild cognitive impairment and cognitive reserve in Parkinson’s disease. Parkinsonism & Related Disorders, 17, 579–586. doi:10.1016/j.parkreldis.2011.03.013
   PubMed Web of Science ®Google Scholar
• Reid, W. G. J., Hely, M. A., Morris, J. G. L., & Halliday, G. M. (2011). Dementia in Parkinson´s disease: A 20-year neuropsychological study (Sydney Multicentre Study). Journal of Neurology, Neurosurgery, and Psychiatry, 82, 1033–1136. doi:10.1136/jnnp.2010.232678
   PubMed Web of Science ®Google Scholar
• Riedel, O., Klotsche, J., Spottke, A., Deuschl, G., Förstl, H., Henn, F., & Wittchen, H. U. (2010). Frequency of dementia, depression, and other neuropsychiatric symptoms in 1,449 outpatients with Parkinson’s disease. Journal of Neurology, 257, 1073–1082. doi:10.1007/s00415-010-5465-z
   PubMed Web of Science ®Google Scholar
• Sawamoto, N., Piccini, P., Hotton, G., Pavese, N., Thielemans, K., & Brooks, D. J. (2008). Cognitive deficits and striato-frontal dopamine release in Parkinson’s disease. Brain, 131, 1294–1302. doi:10.1093/brain/awn054
   PubMed Web of Science ®Google Scholar
• Schapira, A. H. (2015). Glucocerebrosidase and Parkinson disease: Recent advances. Molecular and Cellular Neuroscience, 66, 37–42.
   PubMed Web of Science ®Google Scholar
• Vossius, C., Larsen, J. P., Janvin, C., & Aarsland, D. (2011). The economic impact of cognitive impairment in Parkinson’s disease. Movement Disorders, 26, 1541–1544. doi:10.1002/mds.23661
   PubMed Web of Science ®Google Scholar
• Williams-Gray, C. H., Evans, J. R., Goris, A., Foltynie, T., Ban, M., Robbins, T. W., & Barker, R. A. (2009). The distinct cognitive syndromes of Parkinson’s disease: 5-year follow-up of the CamPaIGN cohort. Brain, 132, 2958–2969. doi:10.1093/brain/awp245
   PubMed Web of Science ®Google Scholar
• Williams-Gray, C. H., Foltynie, T., Brayne, C. E., Robbins, T. W., & Barker, R. A. (2007). Evolution of cognitive dysfunction in an incident Parkinson’s disease cohort. Brain, 130, 1787–1798. doi:10.1093/brain/awm111
   PubMed Web of Science ®Google Scholar